NCT02125019已完成不适用
Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Identify gait and balance parameters that are affected by during adjuvant/neoadjuvant taxane (paclitaxel or docetaxel) chemotherapy.
研究概览
简要总结
Longitudinal Evaluation of Taxane induced neuropathy in early stage breast cancer.
详细描述
A study assessing the feasibility of evaluating neuropathy symptoms prospectively using testing of gate and balance parameters.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Identify gait and balance parameters that are affected by during adjuvant/neoadjuvant taxane (paclitaxel or docetaxel) chemotherapy.
时间窗: Up to 2 years
次要结局
- Evaluate the natural history of changes in these gait and balance parameters and their relationships with validated self-reported assessment tools of CIPN such as CIPN-20 and TNS(Up to 2 years)
- Identify gait and balance changes as a consequence of chemotherapy with paclitaxel or docetaxel in the laboratory measuring the motion of the entire body in three dimensions with great accuracy.(Up to 2 years)
研究者
Nicole Williams
Principal Investigator
Ohio State University Comprehensive Cancer Center
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Early Detection of Taxane-Induced Neuropathy in Women With Breast CancerPeripheral NeuropathyNCT02549534Indiana University29
招募中
不适用
Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast CancerBreast CancerNCT06772935Affiliated Hospital of Qinghai University162
进行中（未招募）
2 期
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerPrognostic Stage IIIC Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Invasive Breast CarcinomaPrognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8NCT04001829ECOG-ACRIN Cancer Research Group249
尚未招募
不适用
Detection of taxane-induced neuropathy using patient-reported outcomesPeripheral neuropathyBreast cancerACTRN12618001378213Royal Adelaide Hospital100
已完成
3 期
4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEFBreast CancerNCT02115204West German Study Group2,011